AER 1490278 is a spontaneous case, received on 11/Nov/2014 from a physician via a company representative, 
and concerns a female patient of unknown age who developed progressive multifocal leukoencephalopathy while 
being treated with rituximab.
No medical history, concurrent conditions, concomitant medications or past drugs were reported.
On an unspecified date, the patient started therapy with rituximab (dose, route, form and frequency not provided) 
for an unknown indication (off label use).  Later, she developed progressive multifocal leukoencephalopathy.
At the time of the report, the outcome of progressive multifocal leukoencephalopathy was not reported and it was 
not known whether therapy with rituximab was ongoing.
Print Time: 26-MAY-2016 01:56 PM If a field is blank, there is no data for that field Page 33 of 675
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
Preferred Term ( MedDRA  Version: 18.0 ReC
The physician did not provide the causal relationship of progressive multifocal leukoencephalopathy with rituximab.
The physician assessed the progressive multifocal leukoencephalopathy as medically significant.
No further information was provided.